These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28155119)

  • 1. A combination of probiotics and magnesium orotate attenuate depression in a small SSRI resistant cohort: an intestinal anti-inflammatory response is suggested.
    Bambling M; Edwards SC; Hall S; Vitetta L
    Inflammopharmacology; 2017 Apr; 25(2):271-274. PubMed ID: 28155119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT.
    Kessler D; Burns A; Tallon D; Lewis G; MacNeill S; Round J; Hollingworth W; Chew-Graham C; Anderson I; Campbell J; Dickens C; Macleod U; Gilbody S; Davies S; Peters TJ; Wiles N
    Health Technol Assess; 2018 Nov; 22(63):1-136. PubMed ID: 30468145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).
    Kessler DS; MacNeill SJ; Tallon D; Lewis G; Peters TJ; Hollingworth W; Round J; Burns A; Chew-Graham CA; Anderson IM; Shepherd T; Campbell J; Dickens CM; Carter M; Jenkinson C; Macleod U; Gibson H; Davies S; Wiles NJ
    BMJ; 2018 Oct; 363():k4218. PubMed ID: 30381374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy outcomes from 3 clinical trials of edivoxetine as adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment.
    Ball SG; Ferguson MB; Martinez JM; Pangallo BA; Nery ES; Dellva MA; Sparks J; Zhang Q; Liu P; Bangs M; Goldberger C
    J Clin Psychiatry; 2016 May; 77(5):635-42. PubMed ID: 27035159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
    Edwards SJ; Hamilton V; Nherera L; Trevor N
    Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for depression.
    Med Lett Drugs Ther; 2016 Jul; 58(1498):85-90. PubMed ID: 27348144
    [No Abstract]   [Full Text] [Related]  

  • 7. Magnesium Orotate and the Microbiome-Gut-Brain Axis Modulation: New Approaches in Psychological Comorbidities of Gastrointestinal Functional Disorders.
    Schiopu C; Ștefănescu G; Diaconescu S; Bălan GG; Gimiga N; Rusu E; Moldovan CA; Popa B; Tataranu E; Olteanu AV; Boloș A; Ștefănescu C
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study.
    Cheon EJ; Lee KH; Park YW; Lee JH; Koo BH; Lee SJ; Sung HM
    J Clin Psychopharmacol; 2017 Apr; 37(2):193-199. PubMed ID: 28129308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study.
    De Berardis D; Fornaro M; Anastasia A; Vellante F; Olivieri L; Rapini G; Serroni N; Orsolini L; Valchera A; Carano A; Tomasetti C; Ventriglio A; Bustini M; Pompili M; Serafini G; Perna G; Iasevoli F; Martinotti G; Di Giannantonio M
    Braz J Psychiatry; 2020; 42(3):317-321. PubMed ID: 32159712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tianeptine combination for partial or non-response to selective serotonin re-uptake inhibitor monotherapy.
    Woo YS; Bahk WM; Jeong JH; Lee SH; Sung HM; Pae CU; Koo BH; Kim W
    Psychiatry Clin Neurosci; 2013 May; 67(4):219-27. PubMed ID: 23683152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minocycline as an adjunct for treatment-resistant depressive symptoms: study protocol for a pilot randomised controlled trial.
    Husain MI; Chaudhry IB; Rahman RR; Hamirani MM; Qurashi I; Khoso AB; Deakin JF; Husain N; Young AH
    Trials; 2015 Sep; 16():410. PubMed ID: 26374703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants.
    Chengappa KN; Kambhampati RK; Perkins K; Nigam R; Anderson T; Brar JS; Vemulapalli HK; Atzert R; Key P; Kang JS; Levine J
    J Clin Psychiatry; 2001 Jul; 62(7):503-8. PubMed ID: 11488359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine.
    Montgomery SA; Nielsen RZ; Poulsen LH; Häggström L
    Hum Psychopharmacol; 2014 Sep; 29(5):470-82. PubMed ID: 25087600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons.
    Vadodaria KC; Ji Y; Skime M; Paquola A; Nelson T; Hall-Flavin D; Fredlender C; Heard KJ; Deng Y; Le AT; Dave S; Fung L; Li X; Marchetto MC; Weinshilboum R; Gage FH
    Mol Psychiatry; 2019 Jun; 24(6):795-807. PubMed ID: 30700803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression.
    McMakin DL; Olino TM; Porta G; Dietz LJ; Emslie G; Clarke G; Wagner KD; Asarnow JR; Ryan ND; Birmaher B; Shamseddeen W; Mayes T; Kennard B; Spirito A; Keller M; Lynch FL; Dickerson JF; Brent DA
    J Am Acad Child Adolesc Psychiatry; 2012 Apr; 51(4):404-11. PubMed ID: 22449646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.
    Liu Y; Zhou X; Zhu D; Chen J; Qin B; Zhang Y; Wang X; Yang D; Meng H; Luo Q; Xie P
    Hum Psychopharmacol; 2015 May; 30(3):132-42. PubMed ID: 25689398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketamine ameliorates severe traumatic event-induced antidepressant-resistant depression in a rat model through ERK activation.
    Lee CW; Chen YJ; Wu HF; Chung YJ; Lee YC; Li CT; Lin HC
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jul; 93():102-113. PubMed ID: 30940482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study).
    McAllister-Williams RH; Smith E; Anderson IM; Barnes J; Gallagher P; Grunze HC; Haddad PM; House AO; Hughes T; Lloyd AJ; McColl EM; Pearce SH; Siddiqi N; Sinha B; Speed C; Steen IN; Wainright J; Watson S; Winter FH; Ferrier IN
    BMC Psychiatry; 2013 Aug; 13():205. PubMed ID: 23914988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot dose-finding clinical trial of creatine monohydrate augmentation to SSRIs/SNRIs/NASA antidepressant treatment in major depression.
    Nemets B; Levine J
    Int Clin Psychopharmacol; 2013 May; 28(3):127-33. PubMed ID: 23466591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered serotonergic circuitry in SSRI-resistant major depressive disorder patient-derived neurons.
    Vadodaria KC; Ji Y; Skime M; Paquola AC; Nelson T; Hall-Flavin D; Heard KJ; Fredlender C; Deng Y; Elkins J; Dani K; Le AT; Marchetto MC; Weinshilboum R; Gage FH
    Mol Psychiatry; 2019 Jun; 24(6):808-818. PubMed ID: 30903001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.